Q32 Bio Ownership | Who Owns Q32 Bio?
Q32 Bio Ownership Summary
Q32 Bio is owned by 73.59% institutional investors, 6.57% insiders, and 19.85% retail investors. Orbimed advisors is the largest institutional shareholder, holding 18.47% of QTTB shares.
QTTB Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Q32 Bio | 73.59% | 6.57% | 19.85% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Orbimed advisors | 2.25M | 18.47% | $3.36M |
Atlas venture life science advisors | 2.09M | 17.15% | $3.12M |
Carlyle group | 1.10M | 9.04% | $1.62M |
Monaco asset management sam | 591.94K | 4.85% | $881.99K |
Arch venture management | 320.48K | 2.63% | $477.52K |
Pfizer | 277.78K | 2.28% | $413.89K |
Sanofi | 244.08K | 2.00% | $363.68K |
Blackrock funding, inc. /de | 178.68K | 1.46% | $266.23K |
Acadian asset management | 29.74K | 0.24% | $44.00K |
Affinity asset advisors | 27.78K | 0.23% | $41.39K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Atlas venture life science advisors | 2.09M | 0.47% | $3.12M |
Sanofi | 244.08K | 0.21% | $363.68K |
Arch venture management | 320.48K | 0.16% | $477.52K |
Monaco asset management sam | 591.94K | 0.15% | $881.99K |
Orbimed advisors | 2.25M | 0.08% | $3.36M |
Pfizer | 277.78K | 0.07% | $413.89K |
Carlyle group | 1.10M | 0.03% | $1.62M |
Affinity asset advisors | 27.78K | 0.01% | $41.39K |
Eversource wealth advisors | 5.30K | 0.00% | $7.90K |
Srs capital advisors | 1.11K | 0.00% | $1.66K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Monaco asset management sam | 591.94K | 0.15% | 86.49K |
Marshall wace, llp | 16.93K | - | 16.93K |
Eversource wealth advisors | 5.30K | 0.00% | 5.21K |
Srs capital advisors | 1.11K | 0.00% | 1.11K |
Mirae asset global investments | 471.00 | - | 63.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Sio capital management | - | - | -697.41K |
Temasek (private) | - | - | -313.94K |
Blackrock funding, inc. /de | 178.68K | - | -278.69K |
Arrowmark colorado | - | - | -81.48K |
Mariner | 11.78K | - | -73.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Marshall wace, llp | 16.93K | - | 16.93K | $25.22K |
Srs capital advisors | 1.11K | 0.00% | 1.11K | $1.66K |
Sold Out
Holder | Change |
---|---|
Thompson investment management | -4.00 |
Farther finance advisors | -6.00 |
Bfsg | -11.00 |
Jones financial companies lllp | -16.00 |
Nisa investment advisors | -20.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 58 | -15.94% | 8,975,903 | 22.91% | 73 | 2.05% | 22 | -12.00% | 19 | -5.00% |
Mar 31, 2025 | 70 | -25.53% | 9,406,755 | -13.54% | 77 | 0.95% | 26 | -57.38% | 20 | 122.22% |
Dec 31, 2024 | 95 | 33.80% | 10,995,641 | 20.72% | 91 | 1.60% | 62 | 40.91% | 9 | 12.50% |
Sep 30, 2024 | 71 | 29.09% | 9,108,413 | 12.93% | 75 | 1.66% | 44 | 25.71% | 8 | 14.29% |
Jun 30, 2024 | 55 | 41.03% | 8,065,328 | 8.55% | 67 | 0.13% | 35 | -7.89% | 7 | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 26, 2025 | Morrison Jodie Pope | CEO | Sell | $18.90K |
Aug 26, 2025 | Violette Shelia M. | Chief Scientific Officer | Sell | $5.38K |
Aug 26, 2025 | Kalowski Lee | CFO and President | Sell | $7.64K |
Mar 25, 2024 | TZIANABOS ARTHUR | - | Sell | $6.41K |
Mar 25, 2024 | Alloway Paul | See Remarks | Sell | $6.49K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 3 |
2025 Q1 | - | - |
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
QTTB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools